WHO Endorses Pfizer’s Antiviral Pill Paxlovid For High-Risk Covid Patients But Says Benefits ‘Trivial’ For Low-Risk Groups There will be 84 fewer people admitted to hospital for every 1,000 people with Covid-19 treated with Paxlovid, new data suggests.